This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (18)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Thomas M. Gilman, PharmD; Yana J. Paulson, PharmD; C. Thomas Boylen, MD; Peter N. R. Heseltine, MB; Om P. Sharma, MD
University of Southern California Schools of Medicine and Pharmacy Los Angeles

JAMA. 1986;256(16):2197-2198.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

We have treated Pneumocystis carinii pneumonia (PCP) with the investigational drug eflornithine (-difluoromethylornithine) in ten patients with acquired immunodeficiency syndrome (AIDS). Eflornithine irreversibly inhibits ornithine decarboxylase and prevents the biosynthesis of putrescine and other polyamines neces . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?